RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Michael J Gonzalez to Clinical Trials as Topic

Back to Details
This is a "connection" page, showing publications Michael J Gonzalez has written about Clinical Trials as Topic.
Michael J Gonzalez
Connection Strength
0.083
Clinical Trials as Topic
  1. Gonz?lez MJ, Miranda-Massari JR, Mora EM, Guzm?n A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Rom?n-Franco A. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integr Cancer Ther. 2005 Mar; 4(1):32-44.
    View in: PubMed
    Score: 0.057
  2. Mateo J, Ong M, Tan DS, Gonzalez MA, de Bono JS. Appraising iniparib, the PARP inhibitor that never was--what must we learn? Nat Rev Clin Oncol. 2013 Dec; 10(12):688-96.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support